BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prescience International Release: Top Executives Deliver Biopharma Dealmaking and CEO Leadership Tools to Cap 2011 University of California, Berkeley (CAL) BioExec Institute


12/2/2011 8:24:32 AM

BERKELEY, CA--(Marketwire - December 01, 2011) - The 2011 UC Berkeley BioExec Institute final fall module will take place Dec. 7-8 at the Haas School of Business.

Bringing together executive leaders in the life sciences from around the globe to address strategies that will help manage business issues of moving innovative science to the marketplace, this two-day module will focus on growing value in biopharma through strategic deal-making and CEO leadership.

"By looking at a variety of significant topics, such as preparing an asset and a biotech company to get the best deal possible, determining how a molecule's commercial value impacts a deal and making sure a contract reflects business realities, executives attending this session of the UC Berkeley BioExec Institute will be armed to negotiate savvy deals," said Melinda Richter, found and CEO, Prescience International, and executive director, San Jose BioCenter.

Delivered by top executives and industry specialists from the Deloitte Life Science Practice, UC Berkeley Center for Executive Education and Prescience International, the Institute deal-making session will feature Rod Ferguson, managing director, Panorama Capital; Tassos E. Gianakakos, senior vice president & chief business officer, MAP Pharmaceuticals, Inc.; Patrick Hagan, senior consultant, Deloitte Recap LLC; Paul J. Hastings, president & CEO, OncoMed Pharmaceuticals, Inc.; Michael S. Johnson, practice leader, Deloitte Recap LLC; Alexander Schuth, MD, associate director business development, head of Neuroscience Partnering, Genentech, Inc.; Laura O. Spiegelman, Spiegelman Life Sciences.

The following day, Dec. 8, UC Berkeley BioExec Institute participants will have the opportunity to be a CEO for the Day -- the final session of the 2011 Institute's series that puts participants in the "corner office" and challenges them to make strategic decisions to move companies to success.

According to Richter, the session will provide participants with simulated real world executive scenarios and interactions.

"Being a successful CEO is a mix of wisdom, team talent and timing. For our last session this year, we have assembled some of the most respected life science CEOs to share their stories and also to challenge our participants to make strategic decisions -- based on little to no information. They will also have the opportunity to role play in situations offering contentious board members as well as disgruntled employees," said Richter. "We also offer up some friendly competition and award the Winner of CEO for a Day based on input by BioExec Faculty and life science CEOs."

In addition to UC Berkeley BioExec Institute instructors, executives taking part in CEO for a Day include Keith Donnermeyer, national life science leader, Deloitte; Peter Hirth, CEO, Plexxicon; Michael S. Johnson, practice leader, Deloitte Recap LLC; Susan Molineaux, CEO, Calithera; Grant Pickering, president & CEO, Juvaris; Entrepreneur in Residence, Kleiner Perkins Caufield & Byers; Jay Sheppard, President & CEO, Nextwave Pharmaceuticals; Dave Summa, managing director, Technology Pathfinders and Eric Walczykowski, managing director, Deloitte Recap.

For more information about the BioExec Institute, please visit, www.executive.berkeley.edu/programs/bioexec-institute, or contact Chelsea Hewitt, (415) 405-6385, or Chelsea@prescienceintl.com. A video overview of the program may be found here, http://www.youtube.com/watch?v=USLMifimz0s

About the UC Berkeley BioExec Institute
Now in its 8th year, the UC Berkeley BioExec Institute is an internationally-renowned executive program delivered by leaders in the industry for life sciences directors and VP-level managers who are searching for the keys to managing business trade-offs within a highly regulated and competitive industry. Delivered by industry specialists, including Deloitte LLP leaders, Prescience International and BioExec Institute faculty and alumni, the Institute offers attendees six-days of interactive programming and features themes surrounding creating, growing and managing value -- the Institute showcases a broad spectrum of speakers representing all aspects of the industry -- from R&D to regulatory to marketing to business development. For more information, http://executive.berkeley.edu/programs/bioexec-institute


Contact:
Steven Brewster
(415) 730-8330
Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES